Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

MilliporeSigma™ Calbiochem™ Gap Junction Enhancer, PQ7

A cell-permeable quinoline derived compound with low toxicity that enhances gap junctional activity by about 16-fold (at ∽500nM) in T47D breast cancer cells and thereby potentiates the effect of chemotherapeutic agents

Manufacturer:  MilliporeSigma™ 5.06216.0001

Catalog No. 50-621-60001


Add to cart

Description

Description

A cell-permeable quinoline derived compound with low toxicity that enhances gap junctional activity by about 16-fold (at ∽500nM) in T47D breast cancer cells and thereby potentiates the effect of chemotherapeutic agents. Blocks T47D cell colony formation (IC50 = 100nM) and reduce the growth of T47D xenograft tumors by 100% in Nu/Nu mice. Increases caspase-3, - 8, and -9 expression by 1.6, 2.8, and 3.8-fold, respectively to induce apoptotic cell death. Can work synergistically with cisplatin to reduce or totally eliminate tumor growth. Increases the expression of connexins 26, 32, and 43 to allow more efficient trafficking of cisplatin.
Specifications

Specifications

98% by HPLC
Protect from Light
C23H19F3N2O3
Tan powder
10mg
DMSO
SDS
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit